Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.

Amy Jo ChienJulia ChambersFiona McauleyTessa KaplanJoseph LetourneauJimmy HwangMi-Ok KimMichelle E MeliskoHope S RugoLaura J EssermanMitchell P Rosen

Published in: Breast cancer research and treatment (2017)

Fertility preservation with OS can be performed in the neoadjuvant setting without delay in initiation of systemic therapy and should be discussed with all early-stage BC patients of reproductive age.

Keyphrases

early stage
rectal cancer
end stage renal disease
lymph node
locally advanced
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
squamous cell carcinoma
stem cells
bone marrow
sentinel lymph node
replacement therapy